Ang CW, Lee BM, Jackson CJ, Wang Y, et al. Nitroimidazopyrazinones with Oral Activity against Tuberculosis and Chagas Disease in Mouse Models of Infection. J Med Chem 2022 Sep 16. doi: 10.1021/acs.jmedchem.2c00972.
PMID: 36111399